SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-002865
Filing Date
2021-02-23
Accepted
2021-02-23 17:15:51
Documents
90
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K espr-20201231.htm   iXBRL 10-K 2322685
2 EX-10.22 ex-1022oberlandamendment.htm EX-10.22 31676
3 EX-10.23 ex-1023koenigemploymentagr.htm EX-10.23 75853
4 EX-10.24 ex-1024hallemploymentagree.htm EX-10.24 64413
5 EX-23.1 ex-231.htm EX-23.1 8555
6 EX-31.1 ex-311.htm EX-31.1 9975
7 EX-31.2 ex-312.htm EX-31.2 10279
8 EX-32.1 ex-321.htm EX-32.1 6299
14 espr-20201231_g1.jpg GRAPHIC 115731
  Complete submission text file 0001628280-21-002865.txt   9745015

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20201231.xsd EX-101.SCH 62045
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20201231_cal.xml EX-101.CAL 86604
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20201231_def.xml EX-101.DEF 329839
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20201231_lab.xml EX-101.LAB 778763
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20201231_pre.xml EX-101.PRE 495244
15 EXTRACTED XBRL INSTANCE DOCUMENT espr-20201231_htm.xml XML 1436093
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35986 | Film No.: 21666789
SIC: 2834 Pharmaceutical Preparations